Axsome Therapeutics (AXSM) shares drop after FDA declines review of fibromyalgia treatment AXS-14. Read more here.

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced ...

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, and Taiwan-based Formosa Pharmaceuticals ('Formosa', 6838.TW), today announced a licensing agreement, whereby Harrow has ...

Bitcoin’s success reflects a growing shift in how the world approaches not only cryptocurrency but also financial markets as ...

Axsome Therapeutics received a refusal-to-file letter from the Food and Drug Administration for its new drug application for its fibromyalgia drug AXS-14.

AXS-14 (esreboxetine) is a highly selective and potent norepinephrine reuptake inhibitor for the management of fibromyalgia ...

How Rick Carter, producer designer of blockbusters for Steven Spielberg and Jim Cameron, sees GenAI emerging as a ...

Content creators have replaced singers and actors as youth idols. This shift affects the economy, consumption, and even ...

RBI's big beautiful monetary policy, rising market activity a cause for concern, global growth slows but markets are soaring, ...

The Nations League final wasn’t Lamine Yamal’s finest hour considering the ridiculous standards that he’d set himself over ...

Critics say renewables can't provide stable power. Supporters say we just need better equipment. Both sides are wrong. We ...

New Paradigm Theatre (NPT) will produce the lively musical Hairspray. Set in 1962 Baltimore, this beloved show captures the spirit of teenagers fighting for racial integration on their favorite TV ...